Summary

Eligibility
for people ages 14-80 (full criteria)
Healthy Volunteers
healthy people welcome
Location
at Irvine, California and other locations
Dates
study started
completion around

Description

Summary

The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupressure analgesia in patients with sickle cell disease (SCD).

Official Title

Remote Self-Administered Acupressure for Pain Management in Patients With Sickle Cell Disease

Details

This study will help the investigators learn whether acupressure, a non-pharmacological alternative treatment approach, can help manage pain in patients with sickle cell disease. Acupressure involves the application of pressure stimulation at specific acupoints on the body. Acupressure may help relieve pain and is used for a wide variety of pain conditions. Participation in this study will consist of remote self-administered treatment every other day over 5 weeks, followed by 6 months of remote follow-up visits. During participation, subjects will: 1) receive detailed instruction on locating treatment acupoints and completing study procedures remotely, 2) be assigned a treatment kit, 3) answer questions about their personal and health-related information for assessing their health condition before, during, and after the treatment during follow-up sessions, and 4) collect inner eyelid images for examining the hemoglobin level on a weekly basis at steady phase and daily basis during acute vaso-occlusive crisis stage.

Keywords

Sickle Cell Disease, Pain, Acupressure, Inner Eyelid Imaging, Sickle Cell Anemia, Acupressure (using AcuWand or pencil eraser)

Eligibility

Locations

  • University of California, Irvine accepting new patients
    Irvine California 92868 United States
  • Indiana University School of Medicine accepting new patients
    Indianapolis Indiana 46075 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Indiana University
ID
NCT06511453
Study Type
Interventional
Participants
Expecting 240 study participants
Last Updated